BioVie Inc. Basic Shares Outstanding (Weighted Average)
BioVie Inc. (BIVI) reported Basic Shares Outstanding (Weighted Average) of 7.25 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- BioVie Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 7.92M shares, a 326.42% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 7.54M shares, a 307.62% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 7.92M shares, a 403.96% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 5.21M shares, a 714.95% increase year-over-year.
- BioVie Inc. weighted average number of shares outstanding, basic for fiscal 2026 was 7.25M shares, a 390.46% increase from fiscal 2025.
- BioVie Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.48M shares.
- BioVie Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 3.25M shares, a 86.83% decline from fiscal 2022.
- BioVie Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 24.66M shares, a 98.84% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.92M shares derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | 7.73M shares derived: average of 2 quarters · filed 2026-08-13 | 7.80M shares derived: average of 3 quarters · filed 2026-08-13 | 7.25M shares 10-K · filed 2026-08-13 | ||||
| 2026-03-31 | 7.54M shares S-1/A · filed 2026-08-06 | 7.73M shares derived: average of 2 quarters · filed 2026-08-06 | 7.02M shares S-1/A · filed 2026-08-06 | 5.63M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 7.92M shares 10-Q · filed 2026-02-06 | 6.57M shares 10-Q · filed 2026-02-06 | 5.00M shares derived: average of 3 quarters · filed 2026-08-13 | 4.21M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | 5.21M shares 10-Q · filed 2025-11-10 | 3.54M shares derived: average of 2 quarters · filed 2026-08-13 | 2.97M shares derived: average of 3 quarters · filed 2026-08-13 | 2.62M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 1.86M shares derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | 1.85M shares derived: average of 2 quarters · filed 2026-08-13 | 1.76M shares derived: average of 3 quarters · filed 2026-08-13 | 1.48M shares 10-K · filed 2026-08-13 | ||||
| 2025-03-31 | 1.85M shares S-1/A · filed 2026-08-06 | 18.51M shares 10-Q · filed 2025-05-12 | 1.71M shares derived: average of 2 quarters · filed 2026-08-06 | 1.35M shares S-1/A · filed 2026-08-06 | 13.50M shares 10-Q · filed 2025-05-12 | -1.52M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2024-12-31 | 1.57M shares 10-Q · filed 2026-02-06 | 15.72M shares 10-Q · filed 2025-02-11 | 1.10M shares 10-Q · filed 2026-02-06 | 11.04M shares 10-Q · filed 2025-02-11 | -2.65M shares derived: average of 3 quarters · filed 2026-08-06 | -865.47K shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2024-09-30 | 639.84K shares 10-Q · filed 2025-11-10 | 6.40M shares 10-Q · filed 2024-11-13 | -4.76M shares derived: average of 2 quarters · filed 2026-08-06 | -1.68M shares derived: average of 3 quarters · filed 2026-08-06 | -304.13K shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2024-06-30 | -10.15M shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | -2.84M shares derived: average of 2 quarters · filed 2026-08-06 | -618.79K shares derived: average of 3 quarters · filed 2026-08-06 | 451.85K shares S-1/A · filed 2026-08-06 | 4.52M shares 10-K · filed 2024-09-30 | |||
| 2024-03-31 | 4.48M shares 10-Q · filed 2025-05-12 | 44.80M shares 10-Q · filed 2024-05-14 | 4.15M shares derived: average of 2 quarters · filed 2025-05-12 | 3.99M shares 10-Q · filed 2025-05-12 | 39.87M shares 10-Q · filed 2024-05-14 | -17.17M shares derived: average of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | 3.82M shares 10-Q · filed 2025-02-11 | 38.17M shares 10-Q · filed 2024-02-13 | 3.74M shares 10-Q · filed 2025-02-11 | 37.44M shares 10-Q · filed 2024-02-13 | -24.39M shares derived: average of 3 quarters · filed 2025-02-11 | -9.46M shares derived: average of 4 quarters · filed 2025-02-11 | ||
| 2023-09-30 | 3.67M shares 10-Q · filed 2024-11-13 | 36.74M shares 10-Q · filed 2023-11-08 | -38.49M shares derived: average of 2 quarters · filed 2024-11-13 | -13.89M shares derived: average of 3 quarters · filed 2024-11-13 | -2.62M shares derived: average of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -80.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -22.67M shares derived: average of 2 quarters · filed 2024-09-30 | -4.72M shares derived: average of 3 quarters · filed 2024-09-30 | 3.25M shares 10-K · filed 2024-09-30 | 32.48M shares 10-K · filed 2023-08-16 | |||
| 2023-03-31 | 35.33M shares 10-Q · filed 2024-05-14 | 33.25M shares derived: average of 2 quarters · filed 2024-05-14 | 31.22M shares 10-Q · filed 2024-05-14 | 29.67M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 31.17M shares 10-Q · filed 2024-02-13 | 29.20M shares 10-Q · filed 2024-02-13 | 27.79M shares derived: average of 3 quarters · filed 2024-02-13 | 27.09M shares derived: average of 4 quarters · filed 2024-02-13 | ||||
| 2022-09-30 | 27.21M shares 10-Q · filed 2023-11-08 | 26.10M shares derived: average of 2 quarters · filed 2023-11-08 | 25.73M shares derived: average of 3 quarters · filed 2023-11-08 | 25.54M shares derived: average of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | 24.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | 24.98M shares derived: average of 2 quarters · filed 2023-08-16 | 24.98M shares derived: average of 3 quarters · filed 2023-08-16 | 24.66M shares 10-K · filed 2023-08-16 | ||||
| 2022-03-31 | 24.98M shares 10-Q · filed 2023-05-12 | 24.97M shares derived: average of 2 quarters · filed 2023-05-12 | 24.56M shares 10-Q · filed 2023-05-12 | 22.37M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 24.96M shares 10-Q · filed 2023-02-10 | 24.34M shares 10-Q · filed 2023-02-10 | 21.50M shares derived: average of 3 quarters · filed 2023-02-10 | 19.60M shares derived: average of 4 quarters · filed 2023-02-10 | ||||
| 2021-09-30 | 23.72M shares 10-Q · filed 2022-11-04 | 19.76M shares derived: average of 2 quarters · filed 2022-11-04 | 17.81M shares derived: average of 3 quarters · filed 2022-11-04 | 16.84M shares derived: average of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | 15.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | 14.86M shares derived: average of 2 quarters · filed 2022-09-27 | 14.55M shares derived: average of 3 quarters · filed 2022-09-27 | 12.40M shares 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | 13.92M shares 10-Q · filed 2022-05-11 | 13.92M shares derived: average of 2 quarters · filed 2022-05-11 | 11.27M shares 10-Q · filed 2022-05-11 | 9.75M shares derived: average of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | 13.92M shares 10-Q · filed 2022-02-08 | 9.97M shares 10-Q · filed 2022-02-08 | 8.36M shares derived: average of 3 quarters · filed 2022-02-08 | 7.57M shares derived: average of 4 quarters · filed 2022-02-08 | ||||
| 2020-09-30 | 5.97M shares 10-Q · filed 2021-11-10 | 5.59M shares derived: average of 2 quarters · filed 2021-11-10 | 5.46M shares derived: average of 3 quarters · filed 2021-11-10 | 5.39M shares derived: average of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | 5.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | 5.20M shares derived: average of 2 quarters · filed 2021-08-30 | 5.19M shares derived: average of 3 quarters · filed 2021-08-30 | 4.93M shares 10-K · filed 2021-08-30 | ||||
| 2020-03-31 | 5.20M shares 10-Q · filed 2021-05-10 | 5.18M shares 10-Q · filed 2020-05-13 | 5.19M shares derived: average of 2 quarters · filed 2021-05-10 | 4.84M shares 10-Q · filed 2021-05-10 | 4.66M shares 10-Q · filed 2020-05-13 | 4.30M shares derived: average of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | 5.18M shares 10-Q · filed 2021-01-29 | 4.66M shares 10-Q · filed 2021-01-29 | 3.99M shares derived: average of 3 quarters · filed 2021-01-29 | 3.63M shares derived: average of 4 quarters · filed 2021-01-29 | ||||
| 2019-09-30 | 4.13M shares 10-Q · filed 2020-11-05 | 3.40M shares derived: average of 2 quarters · filed 2020-11-05 | 3.11M shares derived: average of 3 quarters · filed 2020-11-05 | 2.96M shares derived: average of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | 2.67M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | 2.59M shares derived: average of 2 quarters · filed 2020-08-07 | 2.57M shares derived: average of 3 quarters · filed 2020-08-07 | 2.54M shares 10-K/A · filed 2020-08-07 | ||||
| 2019-03-31 | 2.52M shares 10-Q · filed 2020-05-13 | 2.52M shares derived: average of 2 quarters · filed 2020-05-13 | 2.50M shares 10-Q · filed 2020-05-13 | |||||
| 2018-12-31 | 2.52M shares 10-Q · filed 2020-02-13 | 2.50M shares 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |